Share on Facebook Share on Twitter Email
Answers.com

Anxiety disorder

 
Medical Encyclopedia: Anxiety Disorders

Definition

The anxiety disorders are a group of mental disturbances characterized by anxiety as a central or core symptom. Although anxiety is a commonplace experience, not everyone who experiences it has an anxiety disorder. Anxiety is associated with a wide range of physical illnesses, medication side effects, and other psychiatric disorders.

The revisions of the Diagnostic and Statistical Manual of Mental Disorders (DSM) that took place after 1980 brought major changes in the classification of the anxiety disorders. Prior to 1980, psychiatrists classified patients on the basis of a theory of causality that defined anxiety as the outcome of unconscious conflicts in the patient's mind. DSM-III (1980), DSM-III-R (1987), and DSM-IV (1994) introduced and refined a new classification that took into consideration recent discoveries about the biochemical and post-traumatic origins of some types of anxiety. The present definitions are based on the external and reported symptom patterns of the disorders rather than on theories about their origins.

Description

Anxiety disorders are the most common form of mental disturbance in the United States population. It is estimated that 28 million persons suffer from an anxiety disorder every year. These disorders are a serious problem for the entire society because of their interference with patients' work, schooling, and family life. They also contribute to the high rates of alcohol and substance abuse in the United States. Anxiety disorders are an additional problem for health professionals because the physical symptoms of anxiety frequently bring people to primary care doctors or emergency rooms.

DSM-IV defines twelve types of anxiety disorders in the adult population. They can be grouped under seven headings:

  • Panic disorders with or without agoraphobia. The chief characteristic of panic disorder is the occurrence of panic attacks coupled with fear of their recurrence. In clinical settings, agoraphobia is usually not a disorder by itself, but is typically associated with some form of panic disorder. Patients with agoraphobia are afraid of places or situations in which they might have a panic attack and be unable to leave or to find help. About 25% of patients with panic disorder develop obsessive-compulsive disorder (OCD).
  • Phobias. These include specific phobias and social phobia. A phobia is an intense irrational fear of a specific object or situation that compels the patient to avoid it. Some phobias concern activities or objects that involve some risk (for example, flying or driving) but many are focused on harmless animals or other objects. Social phobia involves a fear of being humiliated, judged, or scrutinized. It manifests itself as a fear of performing certain functions in the presence of others, such as public speaking or using public lavatories.
  • Obsessive-compulsive disorder (OCD). This disorder is marked by unwanted, intrusive, persistent thoughts or repetitive behaviors that reflect the patient's anxiety or attempts to control it. It affects between 2-3% of the population and is much more common than was previously thought.
  • Stress disorders. These include post-traumatic stress disorder (PTSD) and acute stress disorder. Stress disorders are symptomatic reactions to traumatic events in the patient's life.
  • Generalized anxiety disorder (GAD). GAD is the most commonly diagnosed anxiety disorder and occurs most frequently in young adults.
  • Anxiety disorders due to known physical causes. These include general medical conditions or substance abuse.
  • Anxiety disorder not otherwise specified. This last category is not a separate type of disorder, but is included to cover symptoms that do not meet the specific DSM-IV criteria for other anxiety disorders.

All DSM-IV anxiety disorder diagnoses include a criterion of severity. The anxiety must be severe enough to interfere significantly with the patient's occupational or educational functioning, social activities or close relationships, and other customary activities.

The anxiety disorders vary widely in their frequency of occurrence in the general population, age of onset, family patterns, and gender distribution. The stress disorders and anxiety disorders caused by medical conditions or substance abuse are less age-and gender-specific. Whereas OCD affects males and females equally, GAD, panic disorder, and specific phobias all affect women more frequently than men. GAD and panic disorders are more likely to develop in young adults, while phobias and OCD can begin in childhood.

Anxiety disorders in children and adolescents

DSM-IV defines one anxiety disorder as specific to children, namely, separation anxiety disorder. This disorder is defined as anxiety regarding separation from home or family that is excessive or inappropriate for the child's age. In some children, separation anxiety takes the form of school avoidance.

Children and adolescents can also be diagnosed with panic disorder, phobias, generalized anxiety disorder, and the post-traumatic stress syndromes.

— Rebecca J. FreyM



Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
Sci-Tech Encyclopedia: Anxiety disorders
Top

A group of distinct psychiatric disorders characterized by marked emotional distress and social impairment, including generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, and posttraumatic stress disorder.

Generalized anxiety disorder (GAD) is characterized by excessive worry, tension, and anxiety. Accompanying physical symptoms include muscle tension, restlessness, fatigability, and sleep disturbances. GAD occurs in around 4–6% of the population and is the most frequently encountered anxiety disorder in primary care, where sufferers may seek help for the physical symptoms of the disorder. Studies of fear in animals and clinical studies of people with GAD suggest that similar brain circuits are involved in both cases. For example, numerous complex connections to other brain areas allows the amygdala to coordinate cognitive, emotional, and physiological responses to fear and anxiety. Thus in the “fight or flight” response, the organism makes cognitive-affective decisions about how to respond to the perceived danger and has a range of somatic (increased heart and respiration rate) and endocrine (release of stress hormones) responses that act together to increase the likelihood of avoiding the danger. Various neurotransmitter systems are responsible for mediating the communication between the functionally connected regions. Medications acting on these systems are thus effective in treating GAD. Although benzodiazepines have often been used, selective serotonin reuptake inhibitors (SSRIs) and noradrenergic/serotonergic reuptake inhibitors (NSRIs) are currently viewed as first-line options because of their favorable safety profile. Psychotherapy has also proven effective in the treatment of GAD. Cognitive-behavioral psychotherapy focuses on using behavioral techniques and changing underlying thought patterns.

Panic disorder (PD) is characterized by repeated, sudden, and unexpected panic attacks. Panic attacks are accompanied by a range of physical symptoms, including respiratory (shortness of breath), cardiovascular (fast heart rate), gastrointestinal (nausea), and occulovestibular (dizziness) symptoms. The prevalence of PD is approximately 2% in the general population, is more common in women, and is often complicated by depression. The same brain circuits and neurotransmitters implicated in fear and GAD are also likely to play a role in PD. For treatment the first-line choice of medication should be an SSRI or NSRI. Benzodiazepines are effective alone or in combination with SSRIs, but their use as the only medication is generally avoided due to the potential for dependence and withdrawal. Cognitive-behavioral principles that address avoidance behavior and irrational dysfunctional beliefs are also effective.

Obsessive-compulsive disorder (OCD) is characterized by obsessions (unwanted, persistent, distressing thoughts) and compulsions (repetitive acts to relieve anxiety caused by obsessions). The disorder occurs in 2–3% of the population and often begins in childhood or adolescence. OCD is also seen in the context of certain infections, brain injury, and pregnancy. A range of evidence now implicates a brain circuit between the frontal cortex, basal ganglia, and thalamus in mediating OCD. Key neurotransmitters in this circuit include the dopamine and serotonin neurotransmitter system. SSRIs are current first-line treatments for OCD, with dopamine blockers added in those who do not respond to these agents. Behavioral therapy focuses on exposure and response prevention, while cognitive strategies address the distortions in beliefs that underlie the perpetuation of symptoms.

Social anxiety disorder (SAD) is characterized by persistent fears of embarrassment, scrutiny, or humiliation. People with SAD may avoid social situations and performance situations, resulting in marked disability. For some, symptoms are confined to one or more performance situations, while others may be generalized to include most social and performance situations. Generalized SAD is usually more severe and sufferers are more likely to have a family history of SAD. SAD is particularly common, with prevalence figures in some studies upwards of 10%. SAD is often complicated by depression, and people with SAD may self-medicate their symptoms with alcohol, leading to alcohol dependence. Brain-imaging studies have found that effective treatment with medication and psychotherapy normalizes activity in the amygdala and the closely related hippocampal region in SAD. SSRIs, NSRIs, and cognitive-behavioral therapy are all effective in the treatment of SAD. Monoamine oxidase inhibitors (MAOIs) and benzodiazepines are also known to be effective treatments, but have a number of disadvantages.

Posttraumatic stress disorder (PTSD) is an abnormal response to severe trauma. PTSD is characterized by distinct clusters of symptoms: reexperiencing of the event (for example, in flashbacks or dreams), avoidance (of reminders of the trauma), numbing of responsiveness to the environment, and increased arousal (for example, insomnia, irritability, and being easily startled). Although exposure to severe trauma occurs in more than 70% of the population, PTSD has a lifetime prevalence of 7–9% in the general population. Risk factors for developing PTSD following exposure to severe trauma include female gender, previous psychiatric history, trauma severity, and absence of social support after the trauma. Brain-imaging studies have suggested that in PTSD frontal areas of the brain may fail to effectively dampen the “danger alarm” of the amygdala. Whereas stress responses ordinarily recover after exposure to trauma, in PTSD they persist. There is growing evidence that functioning of the hypothalamic-pituitary-adrenal hormonal axis is disrupted in PTSD. However, other systems, such as serotonin and noradrenaline, may also be involved. Both SSRIs and cognitive-behavioral therapy are effective in decreasing PTSD symptoms. Behavioral techniques (using different forms of exposure in the safety of the consultation room) or cognitive retraining (addressing irrational thoughts on the trauma and its consequences) can both be helpful.


Wikipedia: Anxiety disorder
Top
Anxiety disorder
Classification and external resources
ICD-10 F40.-F42.
ICD-9 300
DiseasesDB 787
eMedicine med/152
MeSH D001008

Anxiety disorder is a blanket term covering several different forms of abnormal and pathological fears and anxieties which only came under the aegis of psychiatry at the very end of the 19th century.[1] Current psychiatric diagnostic criteria recognize a wide variety of anxiety disorders. Recent surveys have found that as many as 18% of Americans may be affected by one or more of them.[2]

Contents

Diagnosis

Anxiety disorders are often debilitating chronic conditions, which can be present from an early age or begin suddenly after a triggering event. They are prone to flare up at times of high stress and are frequently accompanied by physiological symptoms such as headache, sweating, muscle spasms, palpitations, and hypertension, which in some cases lead to fatigue or even exhaustion.

Although in casual discourse the words anxiety and fear are often used interchangeably, in clinical usage, they have distinct meanings; anxiety is defined as an unpleasant emotional state for which the cause is either not readily identified or perceived to be uncontrollable or unavoidable, whereas fear is an emotional and physiological response to a recognized external threat. The term anxiety disorder, however, includes fears as well as anxieties. Indeed, phobias (fears which are "persistent or irrational") constitute the majority of anxiety disorder cases.

Anxiety disorders are often comorbid with other mental disorders, particularly clinical depression, which may occur in as many as 60% of people with anxiety disorders. The fact that there is considerable overlap between symptoms of anxiety and depression, and that the same environmental triggers can provoke symptoms in either condition, may help to explain this high rate of comorbidity.[3]

Studies have also indicated that anxiety disorders are more likely among those with family history of anxiety disorders, especially certain types.[4]

Sexual dysfunction also often accompanies anxiety disorders, although it is difficult to determine whether anxiety causes the sexual dysfunction, or whether they arise from a common cause. The most common manifestations in individuals with anxiety disorder are avoidance of intercourse, premature ejaculation or erectile dysfunction among men and pain during intercourse among women. Sexual dysfunction is particularly common among people affected by panic disorder (who may fear that a panic attack will occur during sexual arousal) and posttraumatic stress disorder.[5]

Causes and contributing factors

Clinical and animal studies suggest a correlation between anxiety disorders and difficulty in maintaining balance.[6][7][8][9] A possible mechanism is malfunction in the parabrachial nucleus, a brain structure that, among other functions, coordinates signals from the amygdala with input concerning balance. The amygdala is involved in the emotion of fear.[10]

Especially the basolateral amygdala has been implicated in anxiety generation. A relationship between anxiety and dendritic arborization of the amygdaloid neurons is well known. SK2 potassium channels mediate inhibitory influence on action potentials and reduce arborization. By overexpressing SK2 in the basolateral amygdala, anxiety was reduced and stress-induced corticosterone secretion at a systemic level decreased in an animal model.[11] Mutations in related SK3 are suspected to be a possible underlying cause for several neurological disorders, including anxiety.[citation needed]

Additionally, low levels of GABA, a neurotransmitter that reduces activity in the central nervous system, contribute to anxiety. A number of anxiolytics achieve their effect by modulating the GABA receptors.[12][13][14]

Selective serotonin reuptake inhibitors, the drugs most commonly used to treat depression, are also frequently considered as a first line treatment for anxiety disorders.[15] A recent study using functional brain imaging techniques suggests that the effects of SSRIs in alleviating anxiety may result from a direct action on GABA neurons rather than as a secondary consequence of mood improvement.[16]

Severe anxiety and depression are commonly induced by sustained alcohol abuse which in most cases abates with prolonged abstinence. Even moderate, sustained alcohol use may increase anxiety and depression levels in some individuals.[17] Caffeine, alcohol and benzodiazepines can worsen or cause anxiety and panic attacks.[18] In one study in 1988–1990,[19] illness in approximately half of patients attending mental health services at one British hospital psychiatric clinic, for conditions including anxiety disorders such as panic disorder or social phobia, was determined to be the result of alcohol or benzodiazepine dependence. In these patients, cessation of their anxiety symptoms corresponded with stopping the use of the benzodiazepine or alcohol.

Intoxication from stimulants is likely to be associated with repetitive panic attacks.[citation needed]

There is evidence that chronic exposure to organic solvents in the work environment can be associated with anxiety disorders. Painting, varnishing and carpet laying are some of the jobs in which significant exposure to organic solvents may occur.[20]

Later in life, anxiety disorder can arise in response to life stresses such as financial worries or chronic physical illness. Somewhere between 4% and 10% of older adults are diagnosed with anxiety disorder, a figure which is probably an underestimate due to the tendency of adults to minimize psychiatric problems or to focus on their physical manifestations. Anxiety is also common among older people who have dementia. On the other hand, anxiety disorder is sometimes misdiagnosed among older adults when doctors misinterpret symptoms of a physical ailment (for instance, racing heartbeat due to cardiac arrhythmia) as signs of anxiety.[21]

Types

Generalized anxiety disorder

Generalized anxiety disorder is a common chronic disorder characterized by long-lasting anxiety that is not focused on any one object or situation. Those suffering from generalized anxiety experience non-specific persistent fear and worry and become overly concerned with everyday matters.[22] Generalized anxiety disorder is the most common anxiety disorder to affect older adults.[21]

Panic disorder

In panic disorder, a person suffers from brief attacks of intense terror and apprehension, often marked by trembling, shaking, confusion, dizziness, nausea, difficulty breathing. These panic attacks, defined by the APA as fear or discomfort that abruptly arises and peaks in less than ten minutes, can last for several hours and can be triggered by stress, fear, or even exercise; although the specific cause is not always apparent.

In addition to recurrent unexpected panic attacks, a diagnosis of panic disorder also requires that said attacks have chronic consequences: either worry over the attacks' potential implications, persistent fear of future attacks, or significant changes in behavior related to the attacks. Accordingly, those suffering from panic disorder experience symptoms even outside of specific panic episodes. Often, normal changes in heartbeat are noticed by a panic sufferer, leading them to think something is wrong with their heart or they are about to have another panic attack. In some cases, a heightened awareness (hypervigilance) of body functioning occurs during panic attacks, wherein any perceived physiological change is interpreted as a possible life threatening illness (i.e. extreme hypochondriasis) .

Phobias

The single largest category of anxiety disorders is that of Phobia, which includes all cases in which fear and anxiety is triggered by a specific stimulus or situation. Sufferers typically anticipate terrifying consequences from encountering the object of their fear, which can be anything from an animal to a location to a bodily fluid.

Agoraphobia

Agoraphobia is the specific anxiety about being in a place or situation where escape is difficult or embarrassing.[23] Agoraphobia is strongly linked with panic disorder and is often precipitated by the fear of having a panic attack. A common manifestation involves needing to be in constant view of a door or other escape route. In addition to the fears themselves, the term agoraphobia is often used to refer to avoidance behaviors that sufferers often develop. For example, following a panic attack while driving, someone suffering from agoraphobia may develop anxiety over driving and will therefore avoid driving in the future. These avoidance behaviors can often have serious consequences; in severe cases, one can even be confined to one's home.

Social anxiety disorder

Social anxiety disorder (also known as social phobia) describes an intense fear of negative public scrutiny or of public embarrassment or humiliation. This fear can be specific to particular social situations (such as public speaking) or, more typically, is experienced in most (or all) social interactions. Social anxiety often manifests specific physical symptoms, including blushing, sweating, and difficulty speaking. Like with all phobic disorders, those suffering from social anxiety will attempt to avoid the source of their anxiety; in the case of social anxiety this is particularly problematic, and in severe cases can lead to complete social isolation.

Obsessive-compulsive disorder

Obsessive compulsive disorder is a type of anxiety disorder primarily characterized by repetitive obsessions (distressing, persistent, and intrusive thoughts or images) and compulsions (urges to perform specific acts or rituals). The OCD thought pattern may be likened to superstitions insofar as it involves a belief in a causative relationship where, in reality, one does not exist. Often the process is entirely illogical; for example, the compulsion of walking in a certain pattern may be employed to alleviate the obsession of impending harm. And in many cases, the compulsion is entirely inexplicable, simply an urge to complete a ritual triggered by nervousness.

In a minority of cases, sufferers of OCD may only experience obsessions, with no overt compulsions; a much smaller number of sufferers experience only compulsions.[24]

Post-traumatic stress disorder

Post-traumatic stress disorder or PTSD is an anxiety disorder which results from a traumatic experience. Post-traumatic stress can result from an extreme situation, such as combat, rape, hostage situations, or even serious accident. It can also result from long term (chronic) exposure to a severe stressor,[25] for example soldiers who endure individual battles but cannot cope with continuous combat. Common symptoms include flashbacks, avoidant behaviors, and depression.[24]

Separation anxiety

Separation anxiety disorder is the feeling of excessive and inappropriate levels of anxiety over being separated from a person or place. Separation anxiety itself is a normal part of development in babies or children, and it is only when this feeling is excessive or inappropriate that it can be considered a disorder.[26] Separation anxiety disorder affects roughly 7% of adults and 4% of children, but the childhood cases tend to be more severe, in some instances even a brief separation can produce panic.[27][28]

Treatment

Treatment options available include lifestyle changes; psychotherapy, especially cognitive behavioral therapy; and pharmaceutical therapy. Education, reassurance and some form of cognitive-behavioral therapy should almost always be used in treatment.[citation needed]

When medication is indicated SSRIs, such as fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil) and escitalopram (Lexapro) are generally recommended as first line agents. SNRIs such as venlafaxine (Effexor) are also effective. Benzodiazepines, such as alprazolam (Xanax), clonazepam (Klonopin) and diazepam (Valium) are also sometimes indicated for short-term or PRN use. They are usually considered as a second line treatment due to disadvantages such as cognitive impairment and due to their risks of dependence and withdrawal problems.[29] Other medications commonly prescribed for anxiety disorders include GABA analogues such as gabapentin (Neurontin) or pregabalin (Lyrica), MAOIs such as phenelzine (Nardil) or tranylcypromine (Parnate), as well as the novel antidepressant mirtazapine (Remeron). TCAs such as imipramine, as well as atypical antipsychotics such as quetiapine, and piperazines such as hydroxyzine are also occasionally prescribed.[30]

These medications need to be used with extreme care among older adults, who are more likely to suffer side effects because of coexisting physical disorders. Adherence problems are more likely among elderly patients, who may have difficulty understanding, seeing, or remembering instructions.[21]

Treatment controversy arises because while some studies indicate that a combination of medication and psychotherapy can be more effective than either one alone; others suggest pharmacological interventions are largely palliative, and can actually interfere with the mechanisms of successful therapy.[31] Meta-analysis indicates that psychotherapeutic interventions have superior long-term efficacy when compared to pharmacotherapy.[32] However, the right treatment may very much depend on the individual patient's genetics and environmental factors.

Regular aerobic exercise, improving sleep hygiene and reducing caffeine are often useful in treating anxiety.

See also

Further reading

References

  1. ^ Berrios G.E. (1999) Anxiety Disorders: a conceptual history. Journal of Affective Disorders 56: 83-94.
  2. ^ "Arch Gen Psychiatry – Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication, June 2005, Kessler et al. 62 (6): 617". http://archpsyc.ama-assn.org/cgi/content/full/62/6/617. Retrieved 2007-12-21. 
  3. ^ Cameron OG (December 1, 2007). "Understanding Comorbid Depression and Anxiety". Psychiatric Times 24 (14). http://www.psychiatrictimes.com/anxiety/article/10168/53896. 
  4. ^ McLaughlin K; Behar E, Borkovec T (August 25, 2005). "Family history of psychological problems in generalized anxiety disorder". Journal of Clinical Psychology 64 (7): 905–918. doi:10.1002/jclp.20497. PMID 18509873. http://www3.interscience.wiley.com/journal/119485012/abstract?CRETRY=1&SRETRY=0. 
  5. ^ Coretti G Baldi I (August 1, 2007). "The Relationship Between Anxiety Disorders and Sexual Dysfunction". Psychiatric Times 24 (9). http://www.psychiatrictimes.com/anxiety/article/10168/54881. 
  6. ^ Kalueff, A (2008-01-10). "Anxiety and otovestibular disorders: linking behavioral phenotypes in men and mice.". Behav Brain Res. 186 (1): 1–11. doi:10.1016/j.bbr.2007.07.032. PMID 17822783 : 17822783. 
  7. ^ Nagaratnam, N (May 2005-June). "The vestibular dysfunction and anxiety disorder interface: a descriptive study with special reference to the elderly.". Arch Gerontol Geriatr. 40 (3): 253–64. doi:10.1016/j.archger.2004.09.006. PMID 15814159 : 15814159. 
  8. ^ Lepicard (2000-12-20). "Balance control and posture differences in the anxious BALB/cByJ mice compared to the non anxious C57BL/6J mice.". Behav Brain Res.;(): 117 (1-2): 185–95. PMID 11099772 : 11099772. 
  9. ^ Simon, Naomi (June 1998). "Dizziness and panic disorder: a review of the association between vestibular dysfunction and anxiety.". Ann Clin Psychiatry. 10 (2): 75–80. doi:10.3109/10401239809147746. PMID 9669539 : 9669539. 
  10. ^ Balaban, C (2001 January-April). "Neurological bases for balance-anxiety links.". J Anxiety Disord. 15 (1-2): 53–79. doi:10.1016/S0887-6185(00)00042-6. PMID 11388358 : 11388358. 
  11. ^ "SK2 potassium channel overexpression in basolateral amygdala reduces anxiety, stress-induced corticosterone secretion and dendritic arborization.". 2009 February 10 [Epub ahead of print]. http://www.ncbi.nlm.nih.gov/pubmed/19204724?ordinalpos=51&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum. 
  12. ^ Lydiard (2003). "The role of GABA in anxiety disorders.". J Clin Psychiatry 64 (Suppl 3): 21–7. PMID 12662130 : 12662130. 
  13. ^ Nemeroff (2003). "The role of GABA in the pathophysiology and treatment of anxiety disorders.". Psychopharmacol Bull 37 (4): 133–46. PMID 15131523 : 15131523. 
  14. ^ Enna (1984). "Role of gamma-aminobutyric acid in anxiety.". Psychopathology.;: 17 (Suppl 1): 15–24. PMID 6143341 : 6143341. 
  15. ^ Dunlop BW, Davis PG (2008). "Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review". Prim Care Companion J Clin Psychiatry 10: 22–8. 
  16. ^ Bhagwagar Z, Wylezinska M, Taylor M, Jezzard P, Matthews PM, Cowen PJ (2004). "Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor.". Am J Psychiatry 161 (2): 368–70. doi:10.1176/appi.ajp.161.2.368. PMID 14754790. http://ajp.psychiatryonline.org/cgi/content/full/161/2/368. 
  17. ^ Evans, Katie; Sullivan, Michael J. (1 March 2001). Dual Diagnosis: Counseling the Mentally Ill Substance Abuser (2nd ed.). Guilford Press. pp. 75–76. ISBN 978-1572304468. http://books.google.co.uk/books?id=lvUzR0obihEC. 
  18. ^ Lindsay, S.J.E.; Powell, Graham E., eds (28 July 1998). The Handbook of Clinical Adult Psychology (2nd ed.). Routledge. p. 152-153. ISBN 978-0415072151. http://books.google.co.uk/books?id=a6A9AAAAIAAJ&pg=PA380. 
  19. ^ Cohen SI (February 1995). "Alcohol and benzodiazepines generate anxiety, panic and phobias" (PDF). J R Soc Med 88 (2): 73–7. PMID 7769598. PMC 1295099. http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1295099&blobtype=pdf. 
  20. ^ Morrow LA et al. (2000). "Increased incidence of anxiety and depressive disorders in persons with organic solvent exposure". Psychosomat Med 62 (6): 746–50. PMID 11138992. http://www.psychosomaticmedicine.org/cgi/content/full/62/6/746. 
  21. ^ a b c Calleo J, Stanley M (2008). "Anxiety Disorders in Later Life: Differentiated Diagnosis and Treatment Strategies". Psychiatric Times 26 (8). http://www.psychiatrictimes.com/display/article/10168/1166976. 
  22. ^ Anxiety and Panic disorder
  23. ^ Craske, 2000; Gorman, 2000
  24. ^ a b Psychological Disorders, Psychologie Anglophone
  25. ^ Post-Traumatic Stress Disorder and the Family. Veterans Affairs Canada. 2006. ISBN 0-662-42627-4. http://www.vac-acc.gc.ca/clients/sub.cfm?source=mhealth/ptsd_families#. 
  26. ^ Siegler, Robert (2006). How Children Develop, Exploring Child Develop Student Media Tool Kit & Scientific American Reader to Accompany How Children Develop. New York: Worth Publishers. ISBN 0716761130.
  27. ^ Adult Separation Anxiety Often Overlooked Diagnosis - Arehart-Treichel 41 (13): 30 - Psychiatr News
  28. ^ Prevalence and Correlates of Estimated DSM-IV Child and Adult Separation Anxiety Disorder in the National Comorbidity Survey Replication - Shear et al. 163 (6): 1074 - Am J Psychiatry
  29. ^ Stein, Dan J (16 February 2004). Clinical Manual of Anxiety Disorders (1st ed.). USA: American Psychiatric Press Inc. p. 7. ISBN 978-1585620760. http://books.google.co.uk/books?id=44reFIgFDBMC. 
  30. ^ Llorca PM, Spadone C, Sol O, et al. (November 2002). "Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study". J Clin Psychiatry 63 (11): 1020–7. PMID 12444816. http://www.psychiatrist.com/privatepdf/2002/v63n11/v63n1112.pdf. 
  31. ^ Hollon S; Stewart O, Strunk D (August 25, 2005). "Enduring effects for Cognitive Behavior Therapy in the Treatment of Depression and Anxiety" (PDF). Annual Review of Psychology 57: 285–315. doi:10.1146/annurev.psych.57.102904.190044. PMID 16318597. http://faculty.psy.ohio-state.edu/strunk/personal/Hollon,%20Stewart,%20&%20Strunk%20enduring%20effects%20AR%202006.pdf. 
  32. ^ http://dx.doi.org/10.1016/S0005-7894(97)80048-2

External links


 
 

 

Copyrights:

Medical Encyclopedia. © 2006 through a partnership of Answers Corporation. All rights reserved.  Read more
Sci-Tech Encyclopedia. McGraw-Hill Encyclopedia of Science and Technology. Copyright © 2005 by The McGraw-Hill Companies, Inc. All rights reserved.  Read more
Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Anxiety disorder" Read more